Dell raised AI server guidance 20% to $60B, with traditional servers and PCs also beating expectations. The company is passing through higher input costs to customers, maintaining margins. AI server demand is still in early stages with neoclouds and sovereigns placing multi-billion dollar deals.

Anthropic's ARR grew 500% in 5 months to $47B, justifying AI infrastructure buildout frenzy. Capex is rising due to clear monetization. Profitability concerns will surface later as business model is capital intensive. OpenAI likely to IPO first to own narrative. PE firms like Apollo financing GPU purchases for neoclouds lacking balance sheets.

Blue Origin rocket explosion shows space launch is not easy. SpaceX has huge lead with 160-170 launches last year. SpaceX lowered IPO valuation to $1.8T to set up for success. Valuation comps suggest ~$2T possible: $1B+ from launch (Rocket Lab comp), $600B satellite constellation, $400B AI business. Investors must buy into Elon Musk's long-term vision.

Diabetes tech market set for double-digit growth through 2030. CGM duopoly (Dexcom, Abbott) and insulin pump makers (Beta Bionics, Tandem) are key beneficiaries. Reimbursement expansion into Type 2 diabetes is biggest growth driver. AI helps improve algorithm accuracy for glucose detection and insulin delivery. Non-invasive monitoring via Apple Watch still far off.